Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2023
|
Sundar G. Raman CEO-Fabric & Home Care |
BUY
Grant, award, or other acquisition
|
Direct |
12,456
+33.46%
|
-
|
|
Aug 16
2023
|
Gary A Coombe CEO - Grooming |
BUY
Grant, award, or other acquisition
|
Direct |
18,703
+25.17%
|
-
|
|
Aug 16
2023
|
Andre Schulten Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+5.71%
|
-
|
|
Aug 16
2023
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,812
+10.83%
|
-
|
|
Aug 16
2023
|
Susan Street Whaley Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
1,268
+11.95%
|
-
|
|
Aug 16
2023
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
1,449
+15.74%
|
-
|
|
Aug 16
2023
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
19,682
+29.34%
|
-
|
|
Aug 16
2023
|
Marc S. Pritchard Chief Brand Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,701
+8.43%
|
-
|
|
Aug 16
2023
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,393
+39.64%
|
-
|
|
Aug 16
2023
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
310
+0.86%
|
-
|
|
Aug 16
2023
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,569
+13.62%
|
-
|
|
Aug 16
2023
|
Jennifer L. Davis CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
12,843
+19.53%
|
-
|
|
Aug 09
2023
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
30,000
-96.9%
|
$4,740,000
$158.01 P/Share
|
|
Aug 09
2023
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.21%
|
$2,730,000
$91.07 P/Share
|
|
Aug 03
2023
|
Balaji Purushothaman Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,629
-49.18%
|
$1,982,753
$157.19 P/Share
|
|
Aug 03
2023
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,629
+32.97%
|
$1,073,465
$85.13 P/Share
|
|
Aug 03
2023
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
191
+2.95%
|
-
|
|
Aug 03
2023
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86
+8.12%
|
-
|
|
Aug 01
2023
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
33,022
-92.24%
|
$5,151,432
$156.26 P/Share
|
|
Aug 01
2023
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,022
+47.98%
|
$2,740,826
$83.29 P/Share
|
|
Aug 01
2023
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
8,387
-89.72%
|
$1,308,372
$156.87 P/Share
|
|
Jun 13
2023
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+0.68%
|
-
|
|
Jun 13
2023
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
207
+2.13%
|
-
|
|
Jun 13
2023
|
Robert Jones Portman Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+50.0%
|
-
|
|
Jun 13
2023
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+0.58%
|
-
|
|
Jun 13
2023
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
207
+3.89%
|
-
|
|
Jun 13
2023
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
242
+0.44%
|
-
|
|
Jun 13
2023
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
311
+1.11%
|
-
|
|
Jun 13
2023
|
Christopher J Kempczinski Director |
BUY
Grant, award, or other acquisition
|
Direct |
207
+4.57%
|
-
|
|
May 01
2023
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
31,000
-75.59%
|
$4,836,000
$156.03 P/Share
|
|
May 01
2023
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,000
+43.05%
|
$2,480,000
$80.29 P/Share
|
|
Apr 26
2023
|
Susan Street Whaley Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
4,852
-21.15%
|
$752,060
$155.47 P/Share
|
|
Apr 26
2023
|
Susan Street Whaley Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
2,631
+17.02%
|
$297,303
$113.23 P/Share
|
|
Apr 26
2023
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
13,697
-66.8%
|
$2,123,035
$155.68 P/Share
|
|
Apr 26
2023
|
Matthew W. Janzaruk SVP - Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,422
+46.9%
|
$1,087,182
$81.9 P/Share
|
|
Apr 25
2023
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
14,337
-28.04%
|
$2,250,909
$157.0 P/Share
|
|
Apr 25
2023
|
Gary A Coombe CEO - Grooming |
BUY
Exercise of conversion of derivative security
|
Direct |
14,337
+21.9%
|
$1,218,645
$85.13 P/Share
|
|
Apr 24
2023
|
Balaji Purushothaman Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,300
-48.61%
|
$1,918,800
$156.33 P/Share
|
|
Apr 24
2023
|
Balaji Purushothaman Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,300
+32.71%
|
$1,045,500
$85.13 P/Share
|
|
Apr 24
2023
|
Andre Schulten Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,244
-30.84%
|
$3,912,820
$155.27 P/Share
|
|
Apr 24
2023
|
Andre Schulten Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,220
+27.97%
|
$1,343,160
$78.66 P/Share
|
|
Apr 24
2023
|
Jennifer L. Davis CEO - Health Care |
SELL
Open market or private sale
|
Direct |
23,943
-37.53%
|
$3,711,165
$155.27 P/Share
|
|
Apr 24
2023
|
Jennifer L. Davis CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
23,943
+27.29%
|
$1,867,554
$78.52 P/Share
|
|
Apr 24
2023
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
6,762
-19.8%
|
$1,054,872
$156.12 P/Share
|
|
Apr 24
2023
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,507
-19.95%
|
$233,585
$155.27 P/Share
|
|
Apr 24
2023
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
8,000
-46.13%
|
$1,248,000
$156.84 P/Share
|
|
Mar 14
2023
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
179
+1.89%
|
-
|
|
Mar 14
2023
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
233
+0.53%
|
-
|
|
Mar 14
2023
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+0.4%
|
-
|
|
Mar 14
2023
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
287
+1.04%
|
-
|